TIS 0.00% 0.0¢ tissue therapies limited

defer us trials until cashflow, page-20

  1. 2,243 Posts.
    lightbulb Created with Sketch. 109
    All well and good Thym, but we gotta live within our means...

    I dont want a massive dilution at discounted prices and I can't afford to increase my holdings, given the losses I have had to endure to date. I suspect many other holders are in the same position. There will have to be a large CR at some stage, but it would be best for us all if it was deferred until the company can demonstrate to the market that it is able to execute...and some confidence is restored. That will not happen until we have the CE mark and sales commence.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.